Radioembolization Is a Safe and Effective Treatment for Hepatocellular Carcinoma with Portal Vein Thrombosis: A Propensity Score Analysis. - Wikidata - wikimedia - TriplyDB

Radioembolization Is a Safe and Effective Treatment for Hepatocellular Carcinoma with Portal Vein Thrombosis: A Propensity Score Analysis.

Radioembolization Is a Safe and Effective Treatment for Hepatocellular Carcinoma with Portal Vein Thrombosis: A Propensity Score Analysis.

http://www.wikidata.org/entity/Q36009432

about

Controversies and evidence of hepatic resection for hepatocellular carcinoma VESPRO: An Individual Patient Data Prospective Meta-Analysis of Selective Internal Radiation Therapy Versus Sorafenib for Advanced, Locally Advanced, or Recurrent Hepatocellular Carcinoma of the SARAH and SIRveNIB Trials New Evidence and Perspectives on the Management of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus Single administration of Selective Internal Radiation Therapy versus continuous treatment with sorafeNIB in locally advanced hepatocellular carcinoma (SIRveNIB): study protocol for a phase iii randomized controlled trial.Vasculogenic mimicry in hepatocellular carcinoma contributes to portal vein invasion.Treatment options for unresectable HCC with a focus on SIRT with Yttrium-90 resin microspheres.New concepts in embolotherapy of HCC.Treatment of hepatocellular carcinoma with portal vein tumor thrombus: advances and challenges.Down-regulation of metabolic proteins in hepatocellular carcinoma with portal vein thrombosis.Targeted Radionuclide Therapy: An Evolution Toward Precision Cancer Treatment Combined endovascular brachytherapy, sorafenib, and transarterial chemobolization therapy for hepatocellular carcinoma patients with portal vein tumor thrombus.Hepatocellular Carcinoma with Macrovascular Invasion: Defining the Optimal Treatment Strategy.Safety and Efficacy of Transarterial Radioembolization Combined with Chemoembolization for Bilobar Hepatocellular Carcinoma: A Single-Center Retrospective Study.Therapies for advanced stage hepatocellular carcinoma with macrovascular invasion or metastatic disease: A systematic review and meta-analysis.Local Arterial Therapies in the Management of Unresectable Hepatocellular Carcinoma.Is radioembolization or sorafenib the best option for patients with hepatocellular carcinoma and portal vein invasion?Radioembolization in the setting of liver transplantation: great expectations or hard times?Alternative treatment strategies to sorafenib in patients with advanced hepatocellular carcinoma: a meta-analysis of randomized Phase III trials

P2860

Q28072742-0A41990F-31C9-43BF-8CC1-B2F79CC853BF Q31162270-2DE94C14-77BA-4348-BB6F-F4611F5F7BA3 Q33805289-E62F3391-4405-4E2C-B725-61E6201C7E05 Q36184640-E2622FDA-4831-4972-A28A-EB1EB4AF1784 Q37718478-A99CD514-F401-4B31-8FD2-C0494E31AAAB Q38652404-D8B66639-0695-4F8B-9529-07AF0F418383 Q38904263-CA58F824-55B1-4131-AD6A-B3070D28D01E Q39254708-1B95812F-D7D0-4DD5-AE52-108AFA67BC96 Q41226032-CF351D3E-57C8-4527-BE7C-B0B1B2540A6C Q41475179-6BBAC5DD-A7A1-47C0-91D8-37C7DC904EA9 Q47169633-268F4B6C-69CB-4608-875C-C79CA0543AB3 Q47320483-87231B83-C8B6-4E2E-BB3C-C32EA346335A Q47724444-2414F21B-A67B-4347-ABA7-36650EA57C55 Q48020569-B68BCF0B-79FA-454B-8B19-AEF99F9A921C Q50100582-DF1A065F-0D3E-4216-98BF-19D36568C304 Q50604716-7A72EEBC-5522-4131-88AE-FF1BDB9F816E Q54161340-4FBCB4C3-BB6C-4E98-83CE-3BF0D2FA0E49 Q58700934-B7FEDA88-C409-4AA5-9B20-7267E6356800

P2860

Radioembolization Is a Safe and Effective Treatment for Hepatocellular Carcinoma with Portal Vein Thrombosis: A Propensity Score Analysis.

http://www.wikidata.org/entity/Q36009432

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Radioembolization Is a Safe an ...... : A Propensity Score Analysis.

@ast

Radioembolization Is a Safe an ...... : A Propensity Score Analysis.

@en

type

label

Radioembolization Is a Safe an ...... : A Propensity Score Analysis.

@ast

Radioembolization Is a Safe an ...... : A Propensity Score Analysis.

@en

prefLabel

Radioembolization Is a Safe an ...... : A Propensity Score Analysis.

@ast

Radioembolization Is a Safe an ...... : A Propensity Score Analysis.

@en

P1433

Q36009432-65D4ACCD-F046-4879-941B-5B1D4ADA307A

P1476

Q36009432-813F219A-FF9D-4D40-9214-8890BB48CAA9

P2093

Q36009432-54A50B47-FE43-48D7-9E9E-08FF65AA7664

Q36009432-865A9D7C-B6C6-45AD-8266-D865E419461E

Q36009432-8AE8AEF8-CB31-4147-A92D-813A5461D764

Q36009432-A2CF004B-1D41-47DA-8315-296857EF7B74

Q36009432-C2BF01F9-981D-4146-B74D-87CE5AAA3BE0

Q36009432-C943D289-BD3D-4D99-9D98-FFE4BBF45A34

Q36009432-D35DECBB-F242-4491-824D-2EAAAC779720

Q36009432-DEB5036B-D55E-47D7-87F1-2801DB337FA9

Q36009432-F241DFCA-02EA-4885-8DED-3A4CF882EB64

P2860

Q36009432-01482041-95C3-41B9-9A5D-1F63B6EFB7EB

Q36009432-07115D67-B34F-495F-974E-EB2F33D69874

Q36009432-080CA652-CED8-490B-A3F3-990BF49F18CE

Q36009432-09204BEA-F3E1-442F-8B43-F3AB80F70E69

Q36009432-108FDFF6-DD1F-4529-AD60-2AC33B31AD24

Q36009432-22B9C6FC-1E51-4719-9C57-F0C83FAE104B

Q36009432-4AA46647-E1BD-433A-8DD0-1EA23FC48ACA

Q36009432-4EBEE2D3-094E-49A9-9C76-45CD685F8E06

Q36009432-58644170-F508-4BF6-A932-FB35C7A97C25

Q36009432-5C246B79-F1CD-4985-8D0A-CC6B30B27433

P304

Q36009432-54B67499-0F2D-430A-80FB-DEBD2FFBA863

P31

Q36009432-ECAB8DAF-0A5C-4B4C-9EF6-5A57C9CCD615

P356

Q36009432-AF0AB02B-89BE-4C10-BB88-C184AA08DAFC

P407

Q36009432-6F989549-4653-474A-A8D1-2F6BF2490EC2

P433

Q36009432-B66E6655-AE97-4185-92EE-2054ECB8EDCF

P478

Q36009432-EAEF12FB-D80F-4BBF-972B-002D9359B8FC

P50

Q36009432-8C449AA0-E974-491D-B553-3793129D3A74

P577

Q36009432-8BFBEBF9-87EB-4C15-855F-C88CC7C63C28

P5875

Q36009432-C005C7EB-0976-48F0-B4A4-5557B2072672

P698

Q36009432-AA596D36-FE5D-4680-B938-7B03A24A5284

P921

Q36009432-72F8C924-4985-429D-AF09-6FE2F52FC42A

P932

Q36009432-B1F60F7B-E07D-4D08-A54B-2F6C2549A034

P356

JOURNAL.PONE.0154986

P1433

P1476

Radioembolization Is a Safe an ...... s: A Propensity Score Analysis

@en

P2093

Do Young Kim

http://www.w3.org/2001/XMLSchema#string

Geum-Youn Gwak

http://www.w3.org/2001/XMLSchema#string

Hyo-Cheol Kim

http://www.w3.org/2001/XMLSchema#string

Jeong Heo

http://www.w3.org/2001/XMLSchema#string

Jin Wook Chung

http://www.w3.org/2001/XMLSchema#string

Minjong Lee

http://www.w3.org/2001/XMLSchema#string

Si Hyun Bae

http://www.w3.org/2001/XMLSchema#string

Yoon Jun Kim

http://www.w3.org/2001/XMLSchema#string

Yun Hwan Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Management of hepatocellular carcinoma: An update

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma

Sorafenib in advanced hepatocellular carcinoma

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

Hepatocellular carcinoma

Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma.

An aggressive approach leads to improved survival in hepatocellular carcinoma patients with portal vein tumor thrombus

Comparison of the effects of transarterial chemoembolization for advanced hepatocellular carcinoma between patients with and without extrahepatic metastases

Radioembolization for hepatocellular carcinoma.

Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes.

P304

e0154986

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0154986

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-05-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

301941445

http://www.w3.org/2001/XMLSchema#string

P698

27149067

http://www.w3.org/2001/XMLSchema#string

P921

P932

4858257

http://www.w3.org/2001/XMLSchema#string